Protective effect of caffeic acid phenethyl ester on myocardial injury due to anti-oxidant action

Anadolu Kardiyoloji Dergisi

Volumn 14, Issue 7, 2014, Pages 583-584

  Pan, Defeng ^a   Dongye, Li ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; CAFFEIC ACID PHENETHYL ESTER; CATALASE; CYTOCHROME C OXIDASE; GLUTATHIONE; INTERLEUKIN 1; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROPOLIS; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; OXIDIZING AGENT;

ANTIARRHYTHMIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CELL DAMAGE; EDITORIAL; FREE RADICAL SCAVENGING ASSAY; HEART INFARCTION; HEART MUSCLE INJURY; HEART PROTECTION; HEART RATE; ISCHEMIA; LIVER PROTECTION; NECROSIS; NEUROPROTECTION; OXIDATIVE STRESS; REPERFUSION; SYSTOLIC BLOOD PRESSURE; HUMAN; WISTAR RAT;

ANTIOXIDANTS; HUMANS; OXIDANTS; RATS, WISTAR;

EID: 84910680977     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.124317     Document Type: Editorial

References (14)

1. Viuda-Martos M, Ruiz-Navajas Y, Fernandez-Lopez J, Perez-Alvarez JA. Functional properties of honey, propolis and royal jelly. J Food Sci 2008; 73: R117-24. [CrossRef]
2. Tolba MF, Azab SS, Khalifa AE, Abdel-Rahman SZ, Abdel-Naim AB. Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects. IUBMB Life 2013; 65: 699-709 [CrossRef]
3. Akyol S, Öztürk G, Giniş Z, Armutçu F, Yiğitoğlu MR, Akyol O. In vivo and in vitro antineoplastic actions of caffeic acid phenethyl ester (CAPE): Therapeutic perspectives. Nutr Cancer 2013; 65: 515-26. [CrossRef]
4. Khalil MI, Sulaiman SA. The potential role of honey and its polyphenols in preventing heart diseases: a review. Afr J Tradit Complement Altern Med 2010; 7: 315-21. [CrossRef]
5. İlhan S, Yılmaz N, Nacar E, Motor S, Oktar S, Şahna E. The effect of caffeic acid phenethyl ester on isoproterenol-induced myocardial injury in hypertensive rats. Anadolu Kardiyol Derg 2014; 14: 000-000.
6. Parlakpınar H, Şahna E, Acet A, Mizrak B, Polat A. Protective effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemiareperfusion-induced apoptotic cell death. Toxicology 2005; 209: 1-14. [CrossRef]
7. Iraz M, Fadıllıoğlu E, Taşdemir S, Erdoğan S. Role of vagal activity on bradycardiac and hypotensive effects of caffeic acid phenethyl ester (CAPE). Cardiovasc Toxicol 2005; 5: 391-6. [CrossRef]
8. Long Y, Han M, Chen J, Tian XZ, Chen Q, Wang R. The vasorelaxant effect of caffeic acid phenethyl ester on porcine coronary artery ring segments. Vascul Pharmacol 2009; 51: 78-83. [CrossRef]
9. Hsu LY, Lin CF, Hsu WC, Hsu WL, Chang TC. Evaluation of polyphenolic acid esters as potential antioxidants. Biol Pharm Bull 2005; 28: 1211-5. [CrossRef]
10. Zhang X, Azhar G, Nagano K, Wie JY. Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J Am Coll Cardiol 2001; 38: 2055-62. [CrossRef]
11. Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H2O2 regulates cardiac myocyte phenotype via concentrationdependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003; 35: 615-21. [CrossRef]
12. Okutan H, Özcelik N, Yılmaz HR, Uz E. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem 2005; 38: 191-6. [CrossRef]
13. Yang J, Bowman PD, Kerwin SM, Stavchansky S. Development and validation of an LCMS method to determine the pharmacokinetic profiles of caffeic acid phenethyl amide and caffeic acid phenethyl ester in male Sprague-Dawley rats. Biomed Chromatogr 2014; 28: 241-6. [CrossRef]
14. Ho YJ, Lee AS, Chen WP, Chang WL, Tsai YK, Chiu HL, et al. Caffeic acid phenethyl amide ameliorates ischemia/reperfusion injury and cardiac dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol 2014; 13: 98. [CrossRef]